Peptide Vial
RETATRUTIDE 20MG
$216.00
+ Free ShippingRetatrutide 20mg is a research-grade peptide that activates glucagon, GLP-1, and GIP receptors, aiding in studies related to weight loss and metabolic health. Administered weekly, it offers a unique mechanism for investigating obesity and related conditions.
Availability: 19 in stock
Discount per Quantity
| Quantity | Discount | Price |
|---|---|---|
| 3 - 4 | 5% | $205.20 |
| 5 - 6 | 10% | $194.40 |
| 7 - 9 | 15% | $183.60 |
| 10 - 20 | 20% | $172.80 |
| 21 + | 30% | $151.20 |
Retatrutide 20mg is an investigational peptide developed by Eli Lilly and Company, designed for research purposes only. This novel triple receptor agonist targets the glucagon, GLP-1, and GIP receptors, offering a unique approach to metabolic research. In clinical studies, Retatrutide has demonstrated significant effects on weight reduction, with participants experiencing an average weight loss of up to 24.2% over 48 weeks . Additionally, improvements in liver fat content and reductions in triglyceride levels have been observed . Retatrutide is administered via a once-weekly subcutaneous injection, providing a convenient dosing schedule for research applications. Please note, this product is intended solely for research purposes and is not approved for human or veterinary use.
Important Note: Retatrutide is a research chemical and should only be used by qualified professionals in a controlled laboratory setting. It is not intended for human or animal consumption.
| Rang Qty | 1-2, 3-4, 5-6, 7-9, 10-19, 20+ |
|---|
Reviews
There are no reviews yet.